Research continues in understanding mechanisms of SARS-CoV-2 immune evasion. ProSci offers antibodies & recombinant proteins for SARS-CoV-2 research.
Immune Evasion of SARS-CoV-2
![Immune Evasion of SARS-CoV-2 Immune Evasion of SARS-CoV-2](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/ProSci-600x400px-600x300.png)
Research continues in understanding mechanisms of SARS-CoV-2 immune evasion. ProSci offers antibodies & recombinant proteins for SARS-CoV-2 research.
When it comes to primary cell culture, a picture is worth a thousand words. Follow these tips from ScienCell to get quality microscopy images.
ProSci has developed SARS-CoV-2 variant-specific reagents by focusing on unique point mutations in the spike protein.
mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
CELLvo™ Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes cultured on CELLvo™ Matrix Plus. Achieve maturation in 7 days.
The human leukocyte antigen system, aka human major histocompatibility complex, was named after its discovery with alloantibodies against leukocytes.
LeadGene ELISA kits to quantitatively detect residual protease in samples.
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.